This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Assia Chemical Industries Ltd., Teva Pharmaceuticals International Gmbh. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nandurbar, IN (2021)
- Greater Noida, IN (2021 - 2023)
Company Filing History:

Years Active: 2021-2026
Title: Innovator Spotlight: Bhatu Tumba Patil
Introduction
Bhatu Tumba Patil is a notable inventor based in Greater Noida, India. With a focus on pharmaceutical innovations, he has made significant contributions to the field through his patented technologies. His work primarily revolves around the development of solid-state forms of pharmaceuticals, showcasing his dedication to enhancing drug formulation processes.
Latest Patents
Bhatu holds two patents, both focused on the same groundbreaking innovation: solid state forms of ivosidenib. These patents detail the processes for preparation, pharmaceutical compositions, and various uses of this important compound. The duplication highlights the critical nature of his research and its potential impact on pharmaceutical applications, ensuring more effective treatments for patients.
Career Highlights
At present, Bhatu is associated with Assia Chemical Industries Ltd., where he continues to contribute to pharmaceutical advancements. His expertise in the development of solid-state drugs places him at the forefront of pharmaceutical innovation, enabling the company to deliver improved therapeutic solutions.
Collaborations
During his career, Bhatu has collaborated with talented professionals such as Anantha Rajmohan Muthusamy and Amit Singh. These partnerships have likely enriched his research efforts, fostering creativity and innovation within the field. The synergy between these inventors reflects a commitment to pushing the boundaries of pharmaceutical development.
Conclusion
Bhatu Tumba Patil stands out as an influential figure in the realm of pharmaceuticals due to his innovative patents and collaborative spirit. His contributions not only enhance our understanding of drug formulation but also pave the way for advancements that could significantly improve patient outcomes in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile